Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes
Mark S. Fineman, Larry Z. Shen, Kristin Taylor, Dennis D. Kim, Alain D. BaronVolume:
20
Year:
2004
Language:
english
Pages:
7
DOI:
10.1002/dmrr.499
File:
PDF, 132 KB
english, 2004